tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniel Busby, 7 are a BUY (70%), 3 are a HOLD (30%).
Analyst Daniel Busby, carries an average stock price target met ratio of 79.17% that have a potential upside of 23.95% achieved within 561 days. Previously, Daniel Busby worked at RBC.
Daniel Busby’s has documented 29 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VRCA, Verrica Pharmaceuticals at 15-Aug-2024.
Analyst best performing recommendations are on MNKD (MANNKIND CORP).
The best stock recommendation documented was for MNKD (MANNKIND CORP) at 5/13/2021. The price target of $5 was fulfilled within 46 days with a profit of $0.97 (24.07%) receiving and performance score of 5.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2025
$17
$12.62 (288.13%)
8 months 28 days ago
(18-Dec-2025)
0/2 (0%)
$8.89 (109.62%)
Buy Since 21-Oct-2024
$20
$13.16 (192.40%)
$10
1 years 1 months 2 days ago
(13-Aug-2025)
1/2 (50%)
$13.41 (203.49%)
15
Hold Since 05-Nov-2024
1 years 4 months 1 days ago
(14-May-2025)
3/3 (100%)
$-66.3 (-78.65%)
657
Hold Since 08-Apr-2025
1 years 5 months 7 days ago
(08-Apr-2025)
2/6 (33.33%)
$-80.9 (-85.25%)
602
Buy Since 22-Mar-2023
$3
$-3.84 (-56.14%)
$12
1 years 8 months 9 days ago
(06-Jan-2025)
1/3 (33.33%)
$-3.74 (-55.49%)
141
